Drug Shortage Report for XYLOCAINE VISCOUS 2%
Report ID | 1053 |
Drug Identification Number | 00001686 |
Brand name | XYLOCAINE VISCOUS 2% |
Common or Proper name | lidocaine hydrochloride solution |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | LIQUID |
Route of administration | ORAL TOPICAL |
Packaging size | 1x100mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2016-07-07 |
Actual start date | 2016-07-07 |
Estimated end date | |
Actual end date | 2018-09-24 |
Shortage status | Resolved |
Updated date | 2018-09-25 |
Company comments | AstraZeneca Canada Inc. has transferred the marketing authorization to Aspen Pharmacare Canada Inc. as of July 12, 2018. The drug shortage for Xylocaine Viscous will be posted by Aspen Pharmacare Canada Inc. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-09-25 | English | Compare |
v10 | 2018-09-24 | French | Compare |
v9 | 2018-09-24 | English | Compare |
v8 | 2018-09-24 | English | Compare |
v7 | 2017-03-21 | French | Compare |
v6 | 2017-03-21 | English | Compare |
v5 | 2017-03-21 | English | Compare |
v4 | 2017-03-21 | English | Compare |
v3 | 2017-03-21 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 11 of 11